CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03416244
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:58.100042+00:00
Published At: 2022-09-29T00:00:00+00:00
Record Updated At: 2022-09-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Esophageal Cancer", "Oesophageal Cancer", "Oesophageal Cancer Metastatic", "Esophageal Cancer Metastatic", "Esophageal Cancers NOS", "Oesophageal Cancer Nos", "GastroEsophageal Cancer", "Gastrooesophageal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-09-29"
protocolSection.identificationModule.nctId: "NCT03416244"
protocolSection.identificationModule.officialTitle: "A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.